We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-19.38%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$398M
AUM Growth
-$344M
Cap. Flow
-$248M
Cap. Flow %
-62.23%
Top 10 Hldgs %
44.07%
Holding
188
New
36
Increased
27
Reduced
23
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 30.17%
2 Healthcare 20.63%
3 Industrials 11.87%
4 Utilities 10.14%
5 Consumer Staples 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDK
176
CALL
DELISTED
CDK Global, Inc.
CDK
-5,000
Closed -$313K
ADMS
177
DELISTED
Adamas Pharmaceuticals
ADMS
-510,000
Closed -$10.2M
FLXN
178
DELISTED
Flexion Therapeutics, Inc.
FLXN
-415,000
Closed -$7.76M
ALXN
179
DELISTED
Alexion Pharmaceuticals
ALXN
-114,000
Closed -$15.8M
PE
180
DELISTED
PARSLEY ENERGY INC
PE
-160,000
Closed -$4.68M
WUBA
181
DELISTED
58.com Inc
WUBA
-15,000
Closed -$1.1M
PTLA
182
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-235,000
Closed -$6.26M
PEGI
183
DELISTED
Pattern Energy Group Inc. Class A
PEGI
-80,000
Closed -$1.59M
ZGNX
184
DELISTED
Zogenix, Inc.
ZGNX
-7,000
Closed -$347K
ATVI
185
DELISTED
Activision Blizzard
ATVI
-11,000
Closed -$915K
ORBC
186
DELISTED
ORBCOMM, Inc.
ORBC
-125,000
Closed -$1.36M
VXX
187
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
-25,000
Closed -$667K
CZR
188
DELISTED
Caesars Entertainment Corporation
CZR
-15,000
Closed -$154K

Similar funds

Ardsley Advisory Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ardsley Advisory Partners held 188 positions worth $398M, down 46% from $742M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ardsley Advisory Partners withdrew a net $248M in Q4 2018, closing 84 positions and reducing 23 holdings. Its most notable exit was Marathon Petroleum, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ardsley Advisory Partners opened a new position in CVS Health worth $12.8M.

  • Ardsley Advisory Partners's largest Q4 2018 buy was CVS Health: 195,000 shares worth $12.8M.
  • Ardsley Advisory Partners added most to Celgene Corp in Q4 2018, an estimated $10.8M increase.
  • Ardsley Advisory Partners's biggest Q4 2018 reduction was Progenics Pharmaceuticals Inc, cutting an estimated $7.73M.
  • Ardsley Advisory Partners fully exited Marathon Petroleum in Q4 2018, selling an estimated $27M.
  • Ardsley Advisory Partners's ten largest holdings make up 44% of its $398M portfolio in Q4 2018.
  • Ardsley Advisory Partners opened 36 new positions and closed 84 in Q4 2018.
  • Ardsley Advisory Partners's portfolio value fell 46% quarter-over-quarter to $398M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2018, filed 14 Feb 2019.